Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.
lancegmdx

Hospital Acquired Disease Testing Market Expected To Reach Usd 7.5 Billion Globally In 2019: Transparency Market Research

Furthermore, other testing Farrah Abraham tape solutions for conditions such as surgical site infections and pneumonia (hospital associated and ventilator associated infections) will also experience high demand in lesser developed regions of Asia-Pacific, Latin America and other developing countries where the prevalence of such conditions is higher. It is expected that the market for surgical site infections will grow at a CAGR of 20.1%during the given period of forecast. Geographically, United States and Canada together are the leaders inthe global hospital acquired disease testing market with a combined market share (of talking to the North American region) of 41.3% in 2012. Some of the major growth drivers for the North American nosocomial infection testing market include existence of highly developed healthcare infrastructure, high Farrah teape rate of implementation of healthcare guidelines given by regulatory and guiding institutions such as Centers for Disease Control and Prevention (U.S.), and increasing awareness about these diseases and their prevention. The European Union considers infectious diseases as an increasing threat to the general public health; the public health system in this region is increasingly engaging itself in conducting dialogue between healthcare providers and medical practitioners for developing better, faster and cost effective methods for nosocomial infection management and prevention. Asian countries including China, Philippines and India are the most potential markets for such diagnostic and testing solutions owing to existence of factors such as higher population, poor hospital infrastructure, lack of adherence to sanitation procedures and thereforehigher disease prevalence growth rates. UAE and African countries are some of the lucrative markets in the Rest of the World (RoW). Molecular diagnostics solutions play a vital role in this market as they offer precise, faster and cost effective diagnosis for various nosocomial infections. Considering the market competition, the global hospital acquired infection testing market is highly fragmented and is characterized by the existence of several large and mid-sized diagnostic solution providers.
More: http://finance.yahoo.com/news/hospital-acquired-disease-testing-market-153000200.html

Don't be the product, buy the product!

Schweinderl